Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coherex bags exclusive distribution deal with Abbott

This article was originally published in Clinica

Executive Summary

Coherex Medical is to launch its FlatStent EF system onto the world market after signing an exclusive distribution deal with Abbott. FlatStent EF is designed to close patent foramen ovales (PFOs) using a percutaneous catheter-based approach. Abbott has gained marketing, sales and distribution rights to the product in all countries except for the US and Japan. Coherex will continue to manufacture FlatStent EF out of its Salt Lake City facility. This caps off a busy few months for Coherex – in August the firm clinched $16.5m in a series B financing round (www.clinica.co.uk, August 21 2009), while in July it received a CE mark for FlatStent EF (www.clinica.co.uk, July 9 2009).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044340

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel